These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 10190302)
1. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Damiani S; Ludvikova M; Tomasic G; Bianchi S; Gown AM; Eusebi V Virchows Arch; 1999 Mar; 434(3):227-34. PubMed ID: 10190302 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Werling RW; Hwang H; Yaziji H; Gown AM Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930 [TBL] [Abstract][Full Text] [Related]
3. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast. Prasad ML; Hyjek E; Giri DD; Ying L; O'Leary JJ; Hoda SA Am J Surg Pathol; 1999 Feb; 23(2):176-81. PubMed ID: 9989844 [TBL] [Abstract][Full Text] [Related]
4. Basal cytokeratin phenotypes of myoepithelial cells indicates the origin of ductal carcinomas in situ of the breast. Chen L; Yin X; Lu S; Chen G; Dong L Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):558-64. PubMed ID: 26336082 [TBL] [Abstract][Full Text] [Related]
5. Actin-rich (myoepithelial) cells in ductal carcinoma-in-situ of the breast. Bussolati G; Botta G; Gugliotta P Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 34(3):251-9. PubMed ID: 6108644 [TBL] [Abstract][Full Text] [Related]
6. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression. Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330 [TBL] [Abstract][Full Text] [Related]
7. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast. Dabbs DJ; Gown AM Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102 [TBL] [Abstract][Full Text] [Related]
8. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259 [TBL] [Abstract][Full Text] [Related]
9. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Raymond WA; Leong AS Pathology; 1991 Oct; 23(4):291-7. PubMed ID: 1664512 [TBL] [Abstract][Full Text] [Related]
10. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition. Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153 [TBL] [Abstract][Full Text] [Related]
11. Epithelial hyperplasia of usual type expresses both S100-alpha and S100-beta in a heterogeneous pattern but ductal carcinoma in situ can express only S100-alpha in a monotonous pattern. Ichihara S; Koshikawa T; Nakamura S; Yatabe Y; Kato K Histopathology; 1997 Jun; 30(6):533-41. PubMed ID: 9205857 [TBL] [Abstract][Full Text] [Related]
12. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells. Rohilla M; Bal A; Singh G; Joshi K Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939 [TBL] [Abstract][Full Text] [Related]
14. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Prasad ML; Osborne MP; Hoda SA Anat Pathol; 1998; 3():209-32. PubMed ID: 10389587 [TBL] [Abstract][Full Text] [Related]
15. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of papillary breast lesions. Troxell ML; Masek M; Sibley RK Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625 [TBL] [Abstract][Full Text] [Related]
17. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365 [TBL] [Abstract][Full Text] [Related]
18. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor. Nielsen BS; Rank F; Illemann M; Lund LR; Danø K Int J Cancer; 2007 May; 120(10):2086-95. PubMed ID: 17290405 [TBL] [Abstract][Full Text] [Related]
19. Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma. Hua X; Yu L; Huang X; Liao Z; Xian Q Diagn Pathol; 2011 Nov; 6():111. PubMed ID: 22067528 [TBL] [Abstract][Full Text] [Related]
20. The impact of large sections on the study of in situ and invasive duct carcinoma of the breast. Foschini MP; Flamminio F; Miglio R; Calò DG; Cucchi MC; Masetti R; Eusebi V Hum Pathol; 2007 Dec; 38(12):1736-43. PubMed ID: 17714759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]